Hypoxia-specific gene expression for ischemic disease gene therapy

scientific article published on 23 April 2009

Hypoxia-specific gene expression for ischemic disease gene therapy is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.ADDR.2009.04.009
P698PubMed publication ID19394379
P5875ResearchGate publication ID24360094

P2093author name stringRam I Mahato
Hyun Ah Kim
Minhyung Lee
P433issue7-8
P407language of work or nameEnglishQ1860
P921main subjecthypoxiaQ105688
gene therapyQ213901
P304page(s)614-622
P577publication date2009-04-23
P1433published inAdvanced Drug Delivery ReviewsQ2825362
P1476titleHypoxia-specific gene expression for ischemic disease gene therapy
P478volume61

Reverse relations

cites work (P2860)
Q38479206Activated hypoxia-inducible factor-1α pathway modulates early events in stretch-induced skin neovascularization via stromal cell-derived factor-1 and vascular endothelial growth factor
Q35148901Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice
Q38235326Functional polymers of gene delivery for treatment of myocardial infarct
Q51846343Gene Therapy Used in Cancer Treatment.
Q41958090Hypoxia-inducible factor and vascular endothelial growth factor in the neuroretina and retinal blood vessels after retinal ischemia
Q37489674Hypoxia/hepatoma dual specific suicide gene expression plasmid delivery using bio-reducible polymer for hepatocellular carcinoma therapy
Q39002822Hypoxia: A Double-Edged Sword in Cancer Therapy
Q33740522Lifelong protection from global cerebral ischemia and reperfusion in long-lived Mclk1(+/)(-) mutants
Q36024383Post-translational regulated and hypoxia-responsible VEGF plasmid for efficient secretion
Q36920219Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia
Q39109283Post-translational regulation of gene expression using the ATF4 oxygen-dependent degradation domain for hypoxia-specific gene therapy
Q27001612Receptor tyrosine kinase-mediated angiogenesis
Q36450791Regenerative technology for future therapy of erectile dysfunction
Q52720171Regulation of Tumor Progression by Programmed Necrosis.
Q38703863Targeted delivery of growth factors in ischemic stroke animal models

Search more.